» Articles » PMID: 29977836

Neutrophil-Lymphocyte Ratio As a Prognostic Factor in Laryngeal Carcinoma

Overview
Publisher Springer
Date 2018 Jul 7
PMID 29977836
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim of this study; investigate whether neutrophils/lymphocyte ratio (NLR) could be used as a prognostic factor in larynx cancer. The correlation between preoperative peripheral blood NLR and age, gender, smoking, alcohol use, clinical stage and differentiation degree was examined. One hundered fourty-four patients in Dicle University Department of Otorhinolaryngology between the years of 2005 and 2014 were included in the study. Clinical and preoperative laboratory data of patients were screened retrospectively from archive files of otorhinolaryngology and the pathology results were screened retrospectively from archive files of pathology. The study was approved by the local ethics committee of the department and carried out in accordance with the declaration of Helsinki as amended in 2013. Statistical analyses were performed using the SPSS 15.0 software package for Windows (SPSS inc., Chicago, IL, USA). There was a significant difference between NLR and clinical stage ( = 0.003) smoking ( = 0,001) and alcohol use ( = 0.001). When NLR was analyzed in detail according to the degree of tumor differentiation; significant differences were observed between G1 and G2 ( = 0.007) and between G1 and G3 ( = 0.001). Light of these findings, NLR is a cheap and easily accessible marker which can be used as a prognostic faxtor in laryngeal cancer. It is thougkt to shed light on the studies which will be conducted with more patients.

Citing Articles

Hematological ratios and indices in canine large B-cell lymphoma.

Gavazza A, Cremonini V, Miglio A, Starita C, Rossi G, Antognoni M Open Vet J. 2024; 14(4):980-989.

PMID: 38808287 PMC: 11128634. DOI: 10.5455/OVJ.2024.v14.i4.5.


Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort.

Yang Y, Liang Y, Sadeghi F, Feychting M, Hamar N, Fang F Front Immunol. 2023; 14:1265406.

PMID: 37876941 PMC: 10590876. DOI: 10.3389/fimmu.2023.1265406.


Role and research progress of hematological markers in laryngeal squamous cell carcinoma.

Qi H Diagn Pathol. 2023; 18(1):50.

PMID: 37081512 PMC: 10120220. DOI: 10.1186/s13000-023-01335-7.


Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.

Bojaxhiu B, Sinovcic D, Elicin O, Templeton A, Shelan M, Wartenberg J Radiat Oncol. 2022; 17(1):141.

PMID: 35964056 PMC: 9375277. DOI: 10.1186/s13014-022-02112-4.


Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling.

Xu Y, Zhang Q, Zhou J, Li Z, Guo J, Wang W Biosci Rep. 2019; 39(7).

PMID: 31189744 PMC: 6609596. DOI: 10.1042/BSR20182480.


References
1.
Iovanescu G, Poenaru M, Doros C, Boruga O . Histopathological prognostic and risk factors in patients with laryngeal neoplasms. Rom J Morphol Embryol. 2014; 54(4):1087-92. View

2.
Kowalski L, Franco E, DE ANDRADE SOBRINHO J, Oliveira B, Pontes P . Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol. 1991; 48(2):87-95. DOI: 10.1002/jso.2930480204. View

3.
He J, Shen G, Ren Z, Qin H, Cui C, Zhang Y . Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012; 34(12):1769-76. DOI: 10.1002/hed.22008. View

4.
Gomez D, Farid S, Malik H, Young A, Toogood G, Lodge J . Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008; 32(8):1757-62. DOI: 10.1007/s00268-008-9552-6. View

5.
Lin H, Bhattacharyya N . Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope. 2008; 118(6):1003-13. DOI: 10.1097/MLG.0b013e3181671b3d. View